Screener
Medtronic MDT Other operating segment — Depreciation
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Medtronic in its filing.
Tagged under the XBRL concept us-gaap:Depreciation.
The source filing: Medtronic’s 10-Q, filed February 24, 2026.
- Filed
- Feb 24, 2026, 4:18 PM EST
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-011107
| (in millions) | Three months ended / January 23, 2026 | Three months ended / January 24, 2025 | Nine months ended / January 23, 2026 | Nine months ended / January 24, 2025 |
|---|---|---|---|---|
| Cardiovascular | $66 | $56 | $186 | $167 |
| Neuroscience | 80 | 73 | 235 | 210 |
| Medical Surgical | 62 | 51 | 169 | 152 |
| Diabetes | 32 | 30 | 95 | 81 |
| Total reportable segments | 240 | 211 | 685 | 610 |
| Other operating segment (1) | — | — | — | 1 |
| Corporate | 68 | 57 | 193 | 167 |
| Total | $308 | $268 | $878 | $778 |
Item 1. Financial Statements
FAQ
- What is Medtronic's other operating segment — depreciation?
- Medtronic (MDT) reported other operating segment — depreciation of $0 in Q4 2025.
- What is the long-term trend for Medtronic's other operating segment — depreciation?
- Over 2 years (2022 to 2024), Medtronic's other operating segment — depreciation has grown at a -100.0% compound annual growth rate (CAGR), from $18M to $0.
- What does other operating segment — depreciation mean?
- This metric represents the systematic allocation of the cost of tangible assets used specifically within the company's secondary or non-core operating segments. It reflects the wear and tear or obsolescence of machinery, equipment, and facilities assigned to these business units. Monitoring this helps in understanding the capital intensity and asset replacement cycle of these specific segments.
Ask your AI about Medtronic's other operating segment — depreciation.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude